Carey Douglas Kessler & Ruby PLLC

West Virginia

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases14

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechMech Eng, ManufChemical

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
09/16/24	Regeneron Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 1:22-CV-00061 ( N.D. WV )	ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024)
09/16/24	Regeneron Pharmaceuticals Inc v. Celltrion Inc 1:24-CV-00053 ( N.D. WV )	ORDER of USCA for the Federal Circuit as to 259 Notice of Appeal filed by Samsung Bioepis Co., Ltd., 190 Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., 258 Notice of Appeal filed by Samsung Bioepis, CO., LTD., 175 Notice of Appeal, filed by Samsung Bioepis, CO., LTD., 203 Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, 176 Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) ORDER of USCA for the Federal Circuit as to 259 Notice of Appeal filed by Samsung Bioepis Co., Ltd., 190 Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., 258 Notice of Appeal filed by Samsung Bioepis, CO., LTD., 175 Notice of Appeal, filed by Samsung Bioepis, CO., LTD., 203 Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, 176 Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024)
09/16/24	Regeneron Pharmaceuticals Inc v. Samsung Bioepis Co Ltd 1:23-CV-00094 ( N.D. WV )	ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024)
09/09/24	Boehringer Ingelheim Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 1:24-CV-00082 ( N.D. WV )	AMENDED COMPLAINT [REDACTED] against Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Court-Approved Form AO120)(Pogue, David) (Entered: 09/09/2024)
09/06/24	Bayer Pharma AG v. Mylan Pharmaceuticals Inc 1:21-CV-01742 ( D. DE )	Joint Status Report Regarding Stay, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 9/6/2024 (nms). (Entered: 09/06/2024)
08/28/24	Boehringer Ingelheim Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 1:20-CV-00019 ( N.D. WV )	JOINT STIPULATION AND ORDER TO MODIFY SCHEDULE. (Pretrial Order due by 4/2/2025, Final Pretrial Conference set for 4/9/2025 at 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh, Bench Trial set for 4/14/2025 at 09:30 AM (5 days reserved) in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh.) Signed by Chief District Judge Thomas S. Kleeh on 08/28/2024. (snc) (Entered: 08/28/2024) JOINT STIPULATION AND ORDER TO MODIFY SCHEDULE. (Pretrial Order due by 4/2/2025, Final Pretrial Conference set for 4/9/2025 at 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh, Bench Trial set for 4/14/2025 at 09:30 AM (5 days reserved) in Clarksburg District Judge Courtroom, 2nd Floor before Chief District Judge Thomas S. Kleeh.) Signed by Chief District Judge Thomas S. Kleeh on 08/28/2024. (snc) (Entered: 08/28/2024)
07/26/24	Regeneron Pharmaceuticals Inc v. Celltrion Inc 1:23-CV-00089 ( N.D. WV )	MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 07/26/2024)
07/24/24	Regeneron Pharmaceuticals Inc v. Formycon AG 1:23-CV-00097 ( N.D. WV )	ORDER GRANTING MOTION TO WITHDRAW (ECF NO. 278 ). Terri L. Mascherin shall be TERMINATED as counsel of record. Signed by Chief District Judge Thomas S. Kleeh on 07/24/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/24/2024)
07/16/24	1:24-MD-03103 ( N.D. WV )	USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 258 in 1:24-md-03103-TSK-JPM and 268 in 1:23-cv-00094-TSK-JPM. Notice of Appeal filed by Samsung Bioepis, CO., LTD. Federal Circuit USCA Case Number: 2024-2083. (snc) (Entered: 07/16/2024)
07/16/24	1:24-MD-03103 ( N.D. WV )	USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 250 in 1:23-cv-00106-TSK-JPM and 259 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Samsung Bioepis Co., Ltd. Federal Circuit USCA Case Number: 2024-2082. (snc) (Entered: 07/16/2024)